|
|
|
| Synthesis of Schiff base of adenosine 3’, 5’-cyclicmonophosphoric acid with xanthone and its binding to LC3B |
| ZHOU Chaoqun, TANG Shipeng, QIAN Liangliang, ZHEN Zheng’an, CHENG Rumei |
| School of Ophthalmology & Optometry, School of Biomedical Engineering, Institute of Advanced Materials for Nano-Bio Applications, Wenzhou Medical University, Wenzhou 325027, China |
|
| Cite this article: |
|
ZHOU Chaoqun,TANG Shipeng,QIAN Liangliang, et al. Synthesis of Schiff base of adenosine 3’, 5’-cyclicmonophosphoric acid with xanthone and its binding to LC3B[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2021, 51(7): 570-573.
|
|
|
Abstract Objective: To design the potential proteolysis targeting chimeras (PROTAC) drug S1 synthesized from adenosine 3’, 5’-cyclicmonophosphoric acid and xanthone. Methods: The binding kinetics of S1 and LC3B was characterized by UV-Vis spectroscopy. The resulted data were fitted to first order reaction kinetics.The binding constants and thermodynamic constants of the S1-LC3B complex were determined by fluorescence spectroscopy, and the molecular binding mechanism was deduced. Results: S1 bound to LC3B fast within 160 s.The binding kinetics obeyed the first order reaction kinetics equation and specific transport rule. Thermodynamic
study found that the Gibbs free energy change was negative, indicating a spontaneous binding process. And negative enthalpy change suggested a static attraction between S1 and LC3B. Such course was attributed to the interaction of C=N at S1 with LC3B, resulting in fluorescence quenching. Conclusion: The Schiff base S1 can
spontaneously bind to LC3B.
|
|
Received: 11 December 2020
|
| |
|
|
|
[1] CHEN M, MOILY N, BRIDGFORD J, et al. A thiol probe for measuring unfolded protein load and proteostasis in cells[J]. Nat Commun, 2017, 8(1): 474.
[2] ABDEL-NOUR M, CARNEIRO L, DOWNEY J, et al. The heme-regulated inhibitor is a cytosolic sensor of protein misfolding that controls innate immune signaling[J]. Science,2019, 365(6448): eaaw4144.
[3] CHITI F, DOBSON C. Protein misfolding, formation, and human disease: a summary of progress over the last decade[J]. Ann Rev Biochem, 2017, 86: 27-68.
[4] CHAMBERLAI P, HAMANN L. Development of targeted protein degradation therapeutics[J]. Nat Chem Biol, 2019,15(10): 937-944.
[5] LANGOSCH D, SCHARNAGL C, STEINER H, et al.Understanding intramembrane proteolysis: from protein dynamics to reaction kinetics[J]. Trends Biochem Sci, 2015,40(6): 318-327.
[6] NITZAN A, JORTNER J, KOMMANDEUR J, et al. A quantum mechanical analogue of the Stern-Volmer equation[J]. Chem Phys Lett, 1971, 9(4): 273-278.
[7] GOREN E, REEVES D, AKABAS M. Loose protein packing around the extracellular half of the GABA(A) receptor beta1 subunit M2 channel-lining segment[J]. J Biol Chem, 2004,279(12): 11198-111205.
[8] HURWITZ A. Antacid therapy and drug kinetics[J]. Clin Pharm, 1977, 2(4): 269-280.
[9] CHENG R, ZOU R, OU S, et al. Graphene oxide complex as a pH-sensitive antitumor drug[J]. Polym Chemacokinet,2015, 6(13): 2401-2406.
[10] 刘举, 宫雪, 徐亮, 等.光谱法联合分子对接研究人血清白蛋白与新的抗肿瘤活性小分子的体外结合[J]. 分析测试学报, 2018, 37(4): 389-396. |
|
|
|
